Who owns DexCom, Inc.?
The parent company, the largest shareholders that report their holdings, the funds that own DexCom, Inc. and what its insiders traded, each from the filing that states it.
The short answer
DexCom, Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders, and the GLEIF register names no parent company.
1,054 institutional investors that report to the SEC on Form 13F held 98.2% of its shares on Sep 30, 2026.
The largest of them was BlackRock, Inc. with 10.32%, followed by Vanguard Capital Management LLC (6.62%) and Vanguard Portfolio Management LLC (5.31%).
750 mutual funds registered in 3 countries held 40.0% of the company in their latest reports (the newest of Oct 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's.
In the last 12 months its insiders reported no purchases and 30 sales worth $13 M on SEC Form 4.
Newest figure: Oct 31, 2026.
Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 1,054 holders, 98.2% of the shares together.
| # | Holder | Of the shares | Value | Shares | Change in the quarter |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.32% | $3.3 B | 38.5 M | +0.7% |
| 2 | Vanguard Capital Management LLC | 6.62% | $2.1 B | 24.7 M | -2.0% |
| 3 | Vanguard Portfolio Management LLC | 5.31% | $1.7 B | 19.8 M | +0.7% |
| 4 | State Street Corp | 5.07% | $1.6 B | 18.9 M | +2.8% |
| 5 | Invesco Ltd. | 4.28% | $1.4 B | 16.0 M | +4.5% |
| 6 | Baillie Gifford & Co | 3.89% | $1.3 B | 14.5 M | -1.9% |
| 7 | Geode Capital Management, LLC | 3.34% | $1.1 B | 12.5 M | +0.3% |
| 8 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.74% | $880 M | 10.2 M | -9.4% |
| 9 | Arrowstreet Capital, Limited Partnership | 2.10% | $675 M | 7.8 M | +13.8% |
| 10 | Wellington Management Group LLP | 1.39% | $447 M | 5.2 M | -39.2% |
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Filings read up to Nov 18, 2026; the quarter is still being filed (99% of last quarter's holders so far). People who hold shares in their own name, such as founders, are not in 13F reports
How ownership moved#
Institutions held 98.2% of DexCom, Inc. at Sep 30, 2026, down 4.29 points from Jun 30, 2026; 83 more institutions.
| Quarter end | Institutions | Share of the company | Shares bought | Shares sold | Positions opened | Positions closed |
|---|---|---|---|---|---|---|
| Sep 30, 2026(still being filed) | 1,054 | 98.2% | 33.6 M | 40.3 M | 167 | 103 |
| Jun 30, 2026 | 971 | 102.5% | 42.6 M | 27.1 M | 113 | — |
| Mar 31, 2026 | 950 | 94.2% | — | — | — | — |
| Dec 31, 2025 | 903 | 94.3% | — | — | — | — |
| Sep 30, 2025 | 889 | 94.4% | — | — | — | — |
| Jun 30, 2025 | 924 | 92.6% | — | — | — | — |
| Mar 31, 2025 | 908 | 91.0% | — | — | — | — |
| Dec 31, 2024 | 917 | 91.4% | — | — | — | — |
| Sep 30, 2024 | 864 | 90.3% | — | — | — | — |
| Jun 30, 2024 | 971 | 93.1% | — | — | — | — |
| Mar 31, 2024 | 992 | 91.1% | — | — | — | — |
| Dec 31, 2023 | 928 | 97.4% | — | — | — | — |
| Sep 30, 2023 | 873 | 93.9% | — | — | — | — |
| Jun 30, 2023 | 916 | 93.8% | — | — | — | — |
| Mar 31, 2023 | 865 | 94.0% | — | — | — | — |
| Dec 31, 2022 | 886 | 95.5% | — | — | — | — |
| Sep 30, 2022 | 767 | 94.0% | — | — | — | — |
| Jun 30, 2022 | 772 | 92.3% | — | — | — | — |
| Mar 31, 2022 | 825 | 94.9% | — | — | — | — |
| Dec 31, 2021 | 898 | 94.4% | — | — | — | — |
| Sep 30, 2021 | 765 | 94.9% | — | — | — | — |
Bought most, quarter to Sep 30, 2026
- Schroder Investment Management Group+4.9 M
- Citadel Advisors LLC+2.9 M
- Nuveen, LLC+2.6 M
- Franklin Templeton Inc+1.5 M
- Capital International Investors+1.5 M
- Bank Of America Corp /de/+1.3 M
- Massachusetts Financial Services Co /ma/+1.0 M
- Arrowstreet Capital, Limited Partnership+952,076
Sold most
- Alliancebernstein L.P.−9.3 M
- UBS Group AG−3.6 M
- Wellington Management Group LLP−3.3 M
- Nomura Holdings Inc−1.7 M
- Bank Of Nova Scotia−1.2 M
- Assenagon Asset Management S.A.−1.1 M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC−1.1 M
- Amundi−836,935
New positions (shares held)
- Balyasny Asset Management L.P.459,580
- Jupiter Asset Management LTD397,343
- Carmignac Gestion347,200
- Freestone Grove Partners LP315,774
- Meridiem Capital Partners LP285,963
- Orbimed Advisors LLC278,000
- Driehaus Capital Management LLC149,378
- Prospera Financial Services Inc108,830
Insiders' open-market purchases (up) and sales (down), by quarter
Source: SEC Form 13F data sets and Forms 4 and 5. Institutions report three months after each quarter; a quarter's purchases and sales add up each institution's change since its report for the quarter before. Insiders' trades count open-market purchases and sales only, in the company's reporting currency. 798 mutual funds and ETFs hold DexCom, Inc. in their latest reports: 83 new, 279 adding, 347 cutting.
750 funds in 3 countries held 40.0% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.
| Fund | Manager | Country | Of the company | Value | Report of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 3.28% | $825 M | Jun 30, 2026 |
| Vanguard 500 Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.68% | $674 M | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.24% | $563 M | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | Invesco QQQ Trust, Series 1 | 🇺🇸 | 2.20% | $552 M | Jun 30, 2026 |
| Vanguard Health Care Fund | Wellington Management Company LLP | 🇺🇸 | 1.44% | $449 M | Jul 31, 2026 |
Source: Fund portfolios filed with regulators (SEC Form N-PORT and others) · as of Oct 31, 2026
- Purchases
- 0
- Sales
- 30
- Bought
- $0 M
- Sold
- $13 M
What DexCom, Inc. owns
Companies it owns directly (1 in the GLEIF register)
- DEXCOM OPERATING LTD. GB, READING
Questions and answers#
Who owns DexCom, Inc.?
DexCom, Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders, and the GLEIF register names no parent company. 1,054 institutional investors that report to the SEC on Form 13F held 98.2% of its shares on Sep 30, 2026. The largest of them was BlackRock, Inc. with 10.32%, followed by Vanguard Capital Management LLC (6.62%) and Vanguard Portfolio Management LLC (5.31%).
Who is the largest shareholder of DexCom, Inc.?
Among investors that file SEC Form 13F, BlackRock, Inc. was the largest on Sep 30, 2026, with 10.32% of the shares. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.
How much of DexCom, Inc. do institutional investors own?
1,054 institutional investors that report to the SEC on Form 13F held 98.2% of its shares on Sep 30, 2026.
Does DexCom, Inc. have a parent company?
No. The GLEIF register of legal entities names no parent company of DexCom, Inc.
What companies and brands does DexCom, Inc. own?
The GLEIF register lists 1 company that DexCom, Inc. owns directly, among them DEXCOM OPERATING LTD.
Which mutual funds own DexCom, Inc.?
750 mutual funds registered in 3 countries held 40.0% of the company in their latest reports (the newest of Oct 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.
Sources#
Every figure on this page comes from these, with the date shown next to it.
- GLEIF LEI register, level 2 (who owns whom)
- SEC Form 13F holdings reports
- Fund portfolios filed with regulators (SEC Form N-PORT, Brazil CVM, Sweden Finansinspektionen, Indian fund houses)
- SEC Forms 3, 4 and 5 (insider transactions)
More about DexCom, Inc.#
Questions people ask
Compare head to head
Similar companies by size and industry
- Quest Diagnostics Incorporated$27.8 B
- Mettler-Toledo International Inc.$32.5 B
- Philips$26.8 B
- Labcorp Holdings Inc.$26.3 B
- Guardant Health, Inc.$24.1 B
- Illumina, Inc.$40.7 B